Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2015-003095-68Phase 4Completed
Phase 4, randomised, open-label trial of propofol and clonidine in obstructive sleep apnea hypopnea syndrome (OSAHS) and Sleep Apnea-Hypopnea Syndrome (SAHS) (2 arms), sponsored by Fundació Parc Taulí. Primary endpoint: Proportion of patients reaching N2 sleep without deeper phases. Started Apr 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2015-003095-68.